Literature DB >> 377949

Fluorescent Vi antibody test in the screening of typhoid carriers.

Y K Chitkara, A E Urquhart.   

Abstract

The comparative efficacies of direct bacterial agglutination and immunofluorescent antibody for the estimation of serum Vi antibody were determined in the detection of typhoid carriers. Sera from all 12 typhoid carriers gave significant titers of 1/10 or more in the direct bacterial agglutination test; however, 26 of 119 (21.8%) sera from culture-negative individuals were also falsely positive. In the fluorescent Vi antibody test, 11 of 12 typhoid carriers showed significant serum antibody levels, while only two of 119 (1.7%) culture-negative subjects had significant antibody titers. In view of the much lower false-positive rate, the immunofluorescent Vi antibody test is considered to be superior to the direct bacterial agglutination test in the screening of typhoid carriers.

Mesh:

Substances:

Year:  1979        PMID: 377949     DOI: 10.1093/ajcp/72.1.87

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

Review 1.  Now you see me, now you don't: the interaction of Salmonella with innate immune receptors.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2015-03-09       Impact factor: 60.633

2.  Comparison of the Vi indirect fluorescent antibody test with the Widal agglutination method in the serodiagnosis of typhoid fever.

Authors:  N Doshi; A G Taylor
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

3.  Enzyme-linked immunosorbent assay for detection of human antibodies to Salmonella typhi Vi antigen.

Authors:  T J Barrett; P A Blake; S L Brown; K Hoffman; J M Llort; J C Feeley
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

4.  A Meta-Analysis of Typhoid Diagnostic Accuracy Studies: A Recommendation to Adopt a Standardized Composite Reference.

Authors:  Helen L Storey; Ying Huang; Chris Crudder; Allison Golden; Tala de los Santos; Kenneth Hawkins
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.